Oligonucleotide compound and method for treating nidovirus infections


Autoria(s): Stein, David A.; Bestwick, Richard K.; Iversen, Patrick L.; Neuman, Ben W.; Buchmeier, Michael J.; Weller, Dwight D.
Data(s)

24/06/2014

Resumo

A method and oligonucleotide compound for inhibiting replication of a nidovirus in virus-infected animal cells are disclosed. The compound (i) has a nuclease-resistant backbone, (ii) is capable of uptake by the infected cells, (iii) contains between 8-25 nucleotide bases, and (iv) has a sequence capable of disrupting base pairing between the transcriptional regulatory sequences in the 5′ leader region of the positive-strand viral genome and negative-strand 3′ subgenomic region. In practicing the method, infected cells are exposed to the compound in an amount effective to inhibit viral replication.

Formato

text

Identificador

http://centaur.reading.ac.uk/37088/1/US8759307.pdf

Sarepta Pharmaceuticals, The Scripps Research Institute (2014) Oligonucleotide compound and method for treating nidovirus infections. USOO8759307B2 . doi: USOO8759307B2

Idioma(s)

en

Publicador

Google Patents

Relação

http://centaur.reading.ac.uk/37088/

creatorInternal Neuman, Ben W.

http://www.google.com/patents/US8759307

USOO8759307B2

Tipo

Patent

NonPeerReviewed